Silent
Missense
Nonsense
Frequency of SNVs in pancancer level
| Cancer | Full Name | Mutation | Mutation Type | Sample Number |
|---|---|---|---|---|
| BLCA | Bladder urothelial carcinoma | D113H | Missense | 1 |
| BLCA | Bladder urothelial carcinoma | E110K | Missense | 1 |
| BLCA | Bladder urothelial carcinoma | L460L | Silent | 1 |
| BLCA | Bladder urothelial carcinoma | Q449Q | Silent | 1 |
| BRCA | Breast invasive carcinoma | E110K | Missense | 1 |
| BRCA | Breast invasive carcinoma | G275G | Silent | 1 |
| BRCA | Breast invasive carcinoma | M169I | Missense | 1 |
| BRCA | Breast invasive carcinoma | P390S | Missense | 1 |
| BRCA | Breast invasive carcinoma | S22S | Silent | 1 |
| CESC | Cervical and endocervical cancers | S306* | Nonsense | 1 |
| COAD | Colon adenocarcinoma | K361N | Missense | 1 |
| COAD | Colon adenocarcinoma | R204R | Silent | 1 |
| GBM | Glioblastoma multiforme | V331M | Missense | 1 |
| HNSC | Head and Neck squamous cell carcinoma | E8K | Missense | 1 |
| HNSC | Head and Neck squamous cell carcinoma | L7F | Missense | 1 |
| HNSC | Head and Neck squamous cell carcinoma | S426S | Silent | 1 |
| HNSC | Head and Neck squamous cell carcinoma | V358I | Missense | 1 |
| KIRC | Kidney renal clear cell carcinoma | S437A | Missense | 1 |
| LIHC | Liver hepatocellular carcinoma | C162Y | Missense | 1 |
| LIHC | Liver hepatocellular carcinoma | V282V | Silent | 1 |
| LUAD | Lung adenocarcinoma | E29K | Missense | 1 |
| LUAD | Lung adenocarcinoma | K309K | Silent | 1 |
| LUAD | Lung adenocarcinoma | K453N | Missense | 1 |
| LUAD | Lung adenocarcinoma | P428S | Missense | 1 |
| LUAD | Lung adenocarcinoma | T354S | Missense | 1 |
| OV | Ovarian serous cystadenocarcinoma | D142V | Missense | 1 |
| PRAD | Prostate adenocarcinoma | F262S | Missense | 1 |
| SKCM | Skin Cutaneous Melanoma | G372G | Silent | 1 |
| SKCM | Skin Cutaneous Melanoma | P129S | Missense | 1 |
| SKCM | Skin Cutaneous Melanoma | P49L | Missense | 1 |
| SKCM | Skin Cutaneous Melanoma | Q457K | Missense | 1 |
| STAD | Stomach adenocarcinoma | D107D | Silent | 1 |
| STAD | Stomach adenocarcinoma | V92G | Missense | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | A200A | Silent | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | K91R | Missense | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | L138* | Nonsense | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | R264I | Missense | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | S284T | Missense | 1 |
Mutational percentage of Silent, Missense and Nonsense for various cancers
Summary of mutation in pancancer level
| Cancer | Full Name | # Sample | % Silent | % Missense | % Nonsense |
|---|---|---|---|---|---|
| BLCA | Bladder urothelial carcinoma | 394 | 18.2 | 8 | 0 |
| BRCA | Breast invasive carcinoma | 976 | 18.2 | 12 | 0 |
| CESC | Cervical and endocervical cancers | 194 | 0 | 0 | 50 |
| COAD | Colon adenocarcinoma | 367 | 9.1 | 4 | 0 |
| ESCA | Esophageal carcinoma | 185 | 0 | 0 | 0 |
| GBM | Glioblastoma multiforme | 283 | 0 | 4 | 0 |
| HNSC | Head and Neck squamous cell carcinoma | 511 | 9.1 | 12 | 0 |
| KIRC | Kidney renal clear cell carcinoma | 476 | 0 | 4 | 0 |
| KIRP | Kidney renal papillary cell carcinoma | 282 | 0 | 0 | 0 |
| LAML | Acute Myeloid Leukemia | 192 | 0 | 0 | 0 |
| LGG | Brain Lower Grade Glioma | 516 | 0 | 0 | 0 |
| LIHC | Liver hepatocellular carcinoma | 373 | 9.1 | 4 | 0 |
| LUAD | Lung adenocarcinoma | 533 | 9.1 | 16 | 0 |
| LUSC | Lung squamous cell carcinoma | 177 | 0 | 0 | 0 |
| OV | Ovarian serous cystadenocarcinoma | 465 | 0 | 4 | 0 |
| PAAD | Pancreatic adenocarcinoma | 126 | 0 | 0 | 0 |
| PCPG | Pheochromocytoma and Paraganglioma | 179 | 0 | 0 | 0 |
| PRAD | Prostate adenocarcinoma | 498 | 0 | 4 | 0 |
| READ | Rectum adenocarcinoma | 122 | 0 | 0 | 0 |
| SARC | Sarcoma | 247 | 0 | 0 | 0 |
| SKCM | Skin Cutaneous Melanoma | 290 | 9.1 | 12 | 0 |
| STAD | Stomach adenocarcinoma | 393 | 9.1 | 4 | 0 |
| TGCT | Testicular Germ Cell Tumors | 147 | 0 | 0 | 0 |
| THCA | Thyroid carcinoma | 495 | 0 | 0 | 0 |
| THYM | Thymoma | 119 | 0 | 0 | 0 |
| UCEC | Uterine Corpus Endometrial Carcinoma | 248 | 9.1 | 12 | 50 |